Carregant...
Effect of Denosumab on Bone Mineral Density of Hematopoietic Stem Cell Transplantation Recipients
PURPOSE: Denosumab is a monoclonal antibody that prevents the development of osteoclasts. The effect of denosumab in solid organ transplant recipients has been elucidated, but its effect in haematopoietic stem cell transplantation recipients has not been studied yet. The aim of this study was to det...
Guardat en:
| Publicat a: | Int J Endocrinol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Hindawi
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7218957/ https://ncbi.nlm.nih.gov/pubmed/32454821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/3410921 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|